Prognostic value of revascularising viable myocardium in elderly patients with stable coronary artery disease and

Mehdi Namdar1, Olivier Rager2, Julien Priamo3

  • 1Division of Cardiology, University Hospital Geneva, Geneva, Switzerland.

Insights

Cardiac FDG-PET/CT identifies viable myocardium in elderly patients with coronary artery disease. Revascularization in these patients improves outcomes and survival, suggesting a benefit for this intervention.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Geriatrics

Background:

  • Cardiac viability imaging in elderly patients with coronary artery disease (CAD) and reduced left ventricular ejection fraction (rLVEF) is understudied.
  • FDG-PET/CT is a key imaging modality for assessing myocardial viability.

Purpose of the Study:

  • To evaluate the prognostic value of FDG-PET/CT in elderly patients ( > 65 years) with CAD and rLVEF before revascularization.
  • To determine if viable myocardium identified by FDG-PET/CT predicts outcomes in this population.

Main Methods:

  • Retrospective analysis of 89 elderly patients with CAD and rLVEF undergoing cardiac FDG-PET/CT.
  • Patients were stratified based on the presence of viable myocardium and subsequent revascularization.
  • Clinical endpoints included all-cause mortality and acute cardiac event hospitalizations.

Main Results:

  • Viable myocardium was present in 64 patients.
  • Revascularization was associated with improved left ventricular ejection fraction (LVEF) (3.8 ± 6.6%, P=0.013) compared to no revascularization (-0.75 ± 2.6%, P=0.170).
  • Viable myocardium, if not revascularized, was significantly associated with fatal events (Log-rank P=0.037; multivariate analysis P=0.012).

Conclusions:

  • Elderly patients with viable myocardium demonstrated improved LVEF and survival after revascularization compared to those denied the procedure.
  • Cardiac FDG-PET/CT identified viable myocardium, which was associated with better clinical outcomes in elderly patients when revascularized.
  • FDG-PET/CT can guide revascularization decisions in elderly patients with CAD and rLVEF.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
510
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
728
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
911